Fujun Shang
Impact in
-
- Atherosclerosis and Cardiovascular Diseases
- Mast cells and histamine
-
- Cardiovascular Disease and Adiposity
- Cardiac Fibrosis and Remodeling
Papers in
-
- Blood Pressure and Hypertension Studies 3
- Cardiovascular Function and Risk Factors 3
-
- Signaling Pathways in Disease 2
- ATP Synthase and ATPases Research 2
- Co-authors
- Qiangsun Zheng (7 shared papers)Lianyou Zhao (6 shared papers)Xiongtao Liu (7 shared papers)Yi Wan (4 shared papers)Bin Wang (2 shared papers)Xue Yusheng (2 shared papers)Ye Zhang (2 shared papers)Xiaolin Niu (2 shared papers)
In The Last Decade
Fujun Shang
25 papers receiving 588 citations
Peers
Comparison fields: 5 of 114
- Immunology 142
- Cardiology and Cardiovascular Medicine 148
- Emergency Medical Services 41
- Immunology and Allergy 21
- Physiology 82
Countries citing papers authored by Fujun Shang
This map shows the geographic impact of Fujun Shang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fujun Shang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fujun Shang more than expected).
Fields of papers citing papers by Fujun Shang
This network shows the impact of papers produced by Fujun Shang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fujun Shang. The network helps show where Fujun Shang may publish in the future.
Co-authors
The 25 scholars most cited alongside Fujun Shang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 25 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2011 | 77 | |
| 2 | 2011 | 77 | |
| 3 | 2008 | 68 | |
| 4 | 2007 | 59 | |
| 5 | 2020 | 54 | |
| 6 | 2016 | 44 | |
| 7 | 2020 | 41 | |
| 8 | 2007 | 28 | |
| 9 | 2011 | 27 | |
| 10 | 2006 | 24 | |
| 11 | 2006 | 19 | |
| 12 | 2013 | 14 | |
| 13 | 2007 | 12 | |
| 14 | 2018 | 10 | |
| 15 | 2008 | 9 | |
| 16 | 2008 | 8 | |
| 17 | 2015 | 6 | |
| 18 | 2015 | 5 | |
| 19 | Inhibitory effect of cyclosporin A on growth and collagen synthesis of rat cardiac fibroblasts induced by arginine vasopressin. | 2006 | 5 |
| 20 | 2009 | 4 |
About Fujun Shang
Fujun Shang is a scholar working on Cardiology and Cardiovascular Medicine, Molecular Biology, Immunology, Pathology and Forensic Medicine and Surgery, having authored 25 papers that have together received 602 indexed citations. Recurring topics across this work include Blood Pressure and Hypertension Studies (3 papers), Cardiovascular Function and Risk Factors (3 papers), Neutrophil, Myeloperoxidase and Oxidative Mechanisms (2 papers), Signaling Pathways in Disease (2 papers), ATP Synthase and ATPases Research (2 papers), Sirtuins and Resveratrol in Medicine (2 papers), Pulmonary Hypertension Research and Treatments (2 papers) and Atherosclerosis and Cardiovascular Diseases (2 papers). The work is most often cited by research in Immunology (142 citations), Cardiology and Cardiovascular Medicine (148 citations), Emergency Medical Services (41 citations), Immunology and Allergy (21 citations) and Physiology (82 citations). Fujun Shang has collaborated with scholars based in China, Poland and Canada. Frequent co-authors include Qiangsun Zheng, Lianyou Zhao, Xiongtao Liu, Yi Wan, Bin Wang, Xue Yusheng, Ye Zhang, Xiaolin Niu, Qing Ye and Yongyong Xu. Their work appears in journals such as Blood Pressure Monitoring, Molecular and Cellular Biochemistry, Biomarkers, Journal of Clinical Laboratory Analysis and Journal of Molecular and Cellular Cardiology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.